Daniel S. Korbel

Daniel S. Korbel

Auto-generated profile, based on publicly available information

Daniel S. Korbel

Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2005 in Immunity
Verified
Journal Article
Closed access
MWMichael Walther
Michael Walther
JTJon Eric Tongren
Jon Eric Tongren
LALaura Andrews
Laura Andrews
DKDaniel Korbel
Daniel Korbel
EKElizabeth King
Elizabeth King
AHAdrian V.S. Hill
Adrian V.S. Hill

12 August 2007 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
PNPaul J Norman
Paul J Norman
LALaurent Abi-Rached
Laurent Abi-Rached
KGKetevan Gendzekhadze
Ketevan Gendzekhadze
DKDaniel Korbel
Daniel Korbel
MGMichael Gleimer
Michael Gleimer
PPPeter Parham
Peter Parham

1 July 2008 in Microbes and Infection
Verified
Journal Article
Closed access
DKDaniel S. Korbel
Daniel S. Korbel
BSBianca E. Schneider
Bianca E. Schneider
USUlrich E. Schaible
Ulrich E. Schaible

19 February 2008 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
CHChristoph Hölscher
Christoph Hölscher
NRNorbert Reiling
Norbert Reiling
USUlrich E. Schaible
Ulrich E. Schaible
AHAlexandra Hölscher
Alexandra Hölscher
CBClara Bathmann
Clara Bathmann
SEStefan Ehlers
Stefan Ehlers
The role of Toll‐like receptors (TLR) and MyD88 for immune responses to Mycobacterium tuberculosis (Mtb) infection remains controversial. To address the impact of TLR‐mediated pathogen recognition and MyD88‐dependent signaling events on anti‐mycobacterial host responses, we analyzed the outcome of Mtb infection in TLR2/4/9 triple‐ and MyD88‐deficient mice. After aerosol infection, both TLR2/4/9‐deficient and wild‐type mice expressed pro‐inflammatory cytokines promoting antigen‐specific T cells and the production of IFN‐γ to similar extents. Moreover, TLR2/4/9‐deficient mice expressed IFN‐γ‐dependent inducible nitric oxide synthase and LRG‐47 in infected lungs. MyD88‐deficient mice expressed pro‐inflammatory cytokines and were shown to expand IFN‐γ‐producing antigen‐specific T cells, albeit in a delayed fashion. Only mice that were deficient for MyD88 rapidly succumbed to unrestrained mycobacterial growth, whereas TLR2/4/9‐deficient mice controlled Mtb replication. IFN‐γ‐dependent restriction of mycobacterial growth was severely impaired only in Mtb‐infected MyD88, but not in TLR2/4/9‐deficient bone marrow‐derived macrophages. Our results demonstrate that after Mtb infection neither TLR2, ‐4, and ‐9, nor MyD88 are required for the induction of adaptive T cell responses. Rather, MyD88, but not TLR2, TLR4 and TLR9, is critical for triggering macrophage effector mechanisms central to anti‐mycobacterial defense.

8 March 2012 in Cellular Microbiology
Verified
Journal Article
Open access
PDF file
BCBjörn Corleis
Björn Corleis
DKDaniel Korbel
Daniel Korbel
RWRobert Wilson
Robert Wilson
JBJohan Bylund
Johan Bylund
RCRonnie Chee
Ronnie Chee
USUlrich Emil Schaible
Ulrich Emil Schaible
Neutrophils enter sites of infection, where they can eliminate pathogenic bacteria in an oxidative manner. Despite their predominance in active tuberculosis lesions, the function of neutrophils in this important human infection is still highly controversial. We observed that virulent Mycobacterium tuberculosis survived inside human neutrophils despite prompt activation of these defence cells' microbicidal effectors. Survival of M. tuberculosis was accompanied by necrotic cell death of infected neutrophils. Necrotic cell death entirely depended on radical oxygen species production since chronic granulomatous disease neutrophils were protected from M. tuberculosis‐triggered necrosis. More, importantly, the M.  tuberculosisΔRD1 mutant failed to induce neutrophil necrosis rendering this strain susceptible to radical oxygen species‐mediated killing. We conclude that this virulence function is instrumental for M. tuberculosis to escape killing by neutrophils and contributes to pathogenesis in tuberculosis.

1 June 2010 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
AHAmir Horowitz
Amir Horowitz
KNKirsty C. Newman
Kirsty C. Newman
JEJ. Henry Evans
J. Henry Evans
DKDaniel S. Korbel
Daniel S. Korbel
DDDaniel M. Davis
Daniel M. Davis
EREleanor M. Riley
Eleanor M. Riley
Rapid cell-mediated immune responses, characterized by production of proinflammatory cytokines, such as IFN-γ, can inhibit intraerythrocytic replication of malaria parasites and thereby prevent onset of clinical malaria. In this study, we have characterized the kinetics and cellular sources of the very early IFN-γ response to Plasmodium falciparum-infected RBCs among human PBMCs. We find that NK cells dominate the early (12–18 h) IFN-γ response, that NK cells and T cells contribute equally to the response at 24 h, and that T cells increasingly dominate the response from 48 h onward. We also find that although γδ T cells can produce IFN-γ in response to P. falciparum-infected RBCs, they are greatly outnumbered by αβ T cells, and thus, the majority of the IFN-γ+ T cells are αβ T cells and not γδ T cells; γδ T cells are, however, an important source of TNF. We have previously shown that NK cell responses to P. falciparum-infected RBCs require cytokine and contact-dependent signals from myeloid accessory cells. In this study, we demonstrate that NK cell IFN-γ responses to P. falciparum-infected RBCs are also crucially dependent on IL-2 secreted by CD4+ T cells in an MHC class II-dependent manner, indicating that the innate response to infection actually relies upon complex interactions between NK cells, T cells, and accessory cells. We conclude that activation of NK cells may be a critical function of IL-2–secreting CD4+ T cells and that standard protocols for evaluation of Ag-specific immune responses need to be adapted to include assessment of NK cell activation as well as T cell-derived IL-2.